ArticleNature communications2024
Enhancing piezoelectric coefficient and thermal stability in lead-free piezoceramics: insights at the atomic-scale.
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Evolution of intragranular pores in potassium niobate ceramics during sintering.Nature communications · 2026Article
- Multilayer-induced stress manipulation for superior piezoelectric performance and temperature stability in lead-free piezoceramics.Nature communications · 2026Article
- Beyond MPB engineering: enhanced piezoelectricity and thermal stability assisted by high-entropy design.Nature communications · 2026Article
- Enhanced energy storage in high-entropy superparaelectrics via local ferroelectric polarization.Nature communications · 2026Article
- Beyond phase boundaries: atomic mechanisms governing structure and property variations in (K, Na)NbONature communications · 2025Article
- Sound Insulation Mechanism and Multi-Field Regulation of MXene Dielectric-Tunable Subwavelength Piezoelectric Metamaterials.Materials (Basel, Switzerland) · 2025Article
- Enhanced electrocaloric effect in ferroelectric ceramics via defect dipole engineering.Nature communications · 2025Article
- Achieving Temperature-Insensitive High Piezoelectricity by Reentrant Relaxor Transition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Boosts in Polarization and Piezoelectric Responses of Lead-Free Ferroelectrics through Strain-Enhanced Glassy Coexistent Polars with High Dynamics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Fluctuating local polarization: a generic fingerprint for enhanced piezoelectricity in Pb-based and Pb-free perovskite ferroelectrics.Nature communications · 2025Article
- Eliminating lead-exposure in nebulization therapy by lead-free piezoelectric.Nature communications · 2025Article
- Topology in Biological Piezoelectric Materials.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Dopant-Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- High-entropy assisted capacitive energy storage in relaxor ferroelectrics by chemical short-range order.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Given the highly temperature-sensitive nature of the polymorphic phase boundaries, attaining excellent piezoelectric coefficient with superior temperature stability in lead-free piezoceramics via direct compositional design remains a formidable challenge. We demonstrate the synergistic improvement of piezoelectric coefficient and thermal stability in lead-free piezoceramics via atomic-scale local ferroelectric structure design. Via modulation of the local Landau energy barrier at doping sites, we effectively mitigate fluctuations in piezoelectric d
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.